Quotient Sciences is investing £6.3 million in its recently acquired manufacturing facility in Alnwick, UK, to significantly expand its drug substance manufacturing capability and create 80 new jobs over the next three years.   Quotient acquired the Alnwick facility from Arcinova in February 2021 to expand its services to include drug substance, drug product and clinical testing capabilities under one organization. The acquisition enables Quotient to support customers from candidate selection ...